Literature DB >> 2225084

Study of fibronectin expression in tumour cells by dot-blot and in situ hybridization: quantitative evaluation by image analysis.

L Moro1, M Colombi, S Crespi, R Di Lernia, S Barlati.   

Abstract

An Image Analysis program was used for the quantitative evaluation and comparison of the fibronectin (FN) mRNA detected by dot-blot and in situ hybridization in different cell lines. These techniques were applied for the evaluation of FN mRNA synthesized by human normal fibroblasts (Flow 7000) and by four tumour-derived cell lines (HeLa, epithelioid carcinoma; 8387, fibrosarcoma; RD, rhabdomyosarcoma; SK Hep-1, hepatocarcinoma). Dot-blot analysis showed that the cell types analysed synthesize different levels of FN mRNA. Flow 7000 are the highest producers while HeLa the lowest. In situ hybridization confirmed these results and furthermore showed that while Flow 7000, 8387 and HeLa cells synthesized homogeneous levels of FN mRNA, RD and SK Hep-1 could be subdivided into two populations expressing high or low levels of FN mRNA. The combined analysis of dot-blot, in situ hybridization and Image Analysis allowed the quantitation of the number of FN mRNA molecules expressed by single cells. This approach is therefore an invaluable tool when evaluating mRNA expression in heterogeneous cell populations like tumour-derived cell lines, during cell cycle or in histological tissue sections.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2225084     DOI: 10.1016/0309-1651(90)91189-b

Source DB:  PubMed          Journal:  Cell Biol Int Rep        ISSN: 0309-1651


  2 in total

1.  Expression profiling of mRNA obtained from single identified crustacean motor neurons: determination of specificity of hybridization.

Authors:  R Pekhletski; R L Cooper; H L Atwood; D R Hampson
Journal:  Invert Neurosci       Date:  1996-03

2.  Up-regulation of urokinase-type plasminogen activator in squamous cell carcinoma of human larynx.

Authors:  S Parolini; D Flagiello; A Cinquetti; R Gozzi; S Cristini; J Cappiello; P Nicolai; M Rusnati; M Presta; M M Tosatti
Journal:  Br J Cancer       Date:  1996-10       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.